# Cencora, Inc.: financial statements, quarterly

COR · NYSE · CIK 1140859 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/cor.md) · [Financials](/companies/cor/financials.md) · [Filings](/companies/cor/filings.md) · [Insiders](/companies/cor/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cor/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [68.9 d](/filings/0001140859-25-000131.md) | [72.3](/filings/0001140859-25-000034.md) | [68.4](/filings/0001140859-25-000083.md) | [74.2](/filings/0001140859-25-000122.md) | [79.1 d](/filings/0001140859-25-000131.md) | [81.5](/filings/0001140859-26-000006.md) | [75.5](/filings/0001140859-26-000020.md) | [80.7](/filings/0001140859-26-000034.md) | [83.7 d](/filings/0001140859-25-000131.md) | [85.9](/filings/0001140859-26-000006.md) | [78.4](/filings/0001140859-26-000020.md) | [84.8](/filings/0001140859-26-000034.md) |
| Cost of revenue | $bn | [66.7 d](/filings/0001140859-25-000131.md) | [69.8](/filings/0001140859-25-000034.md) | [65.9](/filings/0001140859-25-000083.md) | [71.8](/filings/0001140859-25-000122.md) | [76.6 d](/filings/0001140859-25-000131.md) | [78.9](/filings/0001140859-26-000006.md) | [72.4](/filings/0001140859-26-000020.md) | [77.8](/filings/0001140859-26-000034.md) | [80.8 d](/filings/0001140859-25-000131.md) | [82.9](/filings/0001140859-26-000006.md) | [74.8](/filings/0001140859-26-000020.md) | [81.1](/filings/0001140859-26-000034.md) |
| Gross profit | $bn | [2.3 d](/filings/0001140859-25-000131.md) | [2.5](/filings/0001140859-25-000034.md) | [2.5](/filings/0001140859-25-000083.md) | [2.4](/filings/0001140859-25-000122.md) | [2.5 d](/filings/0001140859-25-000131.md) | [2.6](/filings/0001140859-26-000006.md) | [3.1](/filings/0001140859-26-000020.md) | [2.9](/filings/0001140859-26-000034.md) | [3.0 d](/filings/0001140859-25-000131.md) | [3.1](/filings/0001140859-26-000006.md) | [3.6](/filings/0001140859-26-000020.md) | [3.6](/filings/0001140859-26-000034.md) |
| Selling, general and administrative | $bn | [1.4 d](/filings/0001140859-25-000131.md) | [1.4](/filings/0001140859-25-000034.md) | [1.4](/filings/0001140859-25-000083.md) | [1.4](/filings/0001140859-25-000122.md) | [1.5 d](/filings/0001140859-25-000131.md) | [1.5](/filings/0001140859-26-000006.md) | [1.6](/filings/0001140859-26-000020.md) | [1.7](/filings/0001140859-26-000034.md) | [1.7 d](/filings/0001140859-25-000131.md) | [1.8](/filings/0001140859-26-000006.md) | [2.0](/filings/0001140859-26-000020.md) | [2.1](/filings/0001140859-26-000034.md) |
| Operating income | $bn | [0.5 d](/filings/0001140859-25-000131.md) | [0.8](/filings/0001140859-25-000034.md) | [0.6](/filings/0001140859-25-000083.md) | [0.7](/filings/0001140859-25-000122.md) | [0.1 d](/filings/0001140859-25-000131.md) | [0.7](/filings/0001140859-26-000006.md) | [1.0](/filings/0001140859-26-000020.md) | [0.9](/filings/0001140859-26-000034.md) | [0.0 d](/filings/0001140859-25-000131.md) | [0.8](/filings/0001140859-26-000006.md) | [1.1](/filings/0001140859-26-000020.md) | [1.1](/filings/0001140859-26-000034.md) |
| Income tax | $bn | [0.1 d](/filings/0001140859-25-000131.md) | [0.2](/filings/0001140859-25-000034.md) | [0.0](/filings/0001140859-25-000083.md) | [0.1](/filings/0001140859-25-000122.md) | [0.1 d](/filings/0001140859-25-000131.md) | [0.1](/filings/0001140859-26-000006.md) | [0.2](/filings/0001140859-26-000020.md) | [0.2](/filings/0001140859-26-000034.md) | [0.1 d](/filings/0001140859-25-000131.md) | [0.1](/filings/0001140859-26-000006.md) | [0.5](/filings/0001140859-26-000020.md) | [0.2](/filings/0001140859-26-000034.md) |
| Net income | $bn | [0.4 d](/filings/0001140859-25-000131.md) | [0.6](/filings/0001140859-25-000034.md) | [0.4](/filings/0001140859-25-000083.md) | [0.5](/filings/0001140859-25-000122.md) | [0.0 d](/filings/0001140859-25-000131.md) | [0.5](/filings/0001140859-26-000006.md) | [0.7](/filings/0001140859-26-000020.md) | [0.7](/filings/0001140859-26-000034.md) | [(0.3) d](/filings/0001140859-25-000131.md) | [0.6](/filings/0001140859-26-000006.md) | [1.6](/filings/0001140859-26-000020.md) | [0.8](/filings/0001140859-26-000034.md) |
| Diluted EPS | $ per share | not reported | [2.98](/filings/0001140859-25-000034.md) | [2.09](/filings/0001140859-25-000083.md) | [2.42](/filings/0001140859-25-000122.md) | not reported | [2.50](/filings/0001140859-26-000006.md) | [3.68](/filings/0001140859-26-000020.md) | [3.52](/filings/0001140859-26-000034.md) | not reported | [2.87](/filings/0001140859-26-000006.md) | [8.40](/filings/0001140859-26-000020.md) | [3.94](/filings/0001140859-26-000034.md) |
| Basic EPS | $ per share | not reported | [3.01](/filings/0001140859-25-000034.md) | [2.11](/filings/0001140859-25-000083.md) | [2.44](/filings/0001140859-25-000122.md) | not reported | [2.52](/filings/0001140859-26-000006.md) | [3.70](/filings/0001140859-26-000020.md) | [3.55](/filings/0001140859-26-000034.md) | not reported | [2.88](/filings/0001140859-26-000006.md) | [8.44](/filings/0001140859-26-000020.md) | [3.95](/filings/0001140859-26-000034.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [2.6](/filings/0001140859-25-000131.md) | [2.9](/filings/0001140859-25-000034.md) | [2.1](/filings/0001140859-25-000083.md) | [3.3](/filings/0001140859-25-000122.md) | [3.1](/filings/0001140859-26-000034.md) | [3.2](/filings/0001140859-26-000006.md) | [2.0](/filings/0001140859-26-000020.md) | [2.2](/filings/0001140859-26-000034.md) | [4.4](/filings/0001140859-26-000034.md) | [1.8](/filings/0001140859-26-000006.md) | [2.2](/filings/0001140859-26-000020.md) | [2.8](/filings/0001140859-26-000034.md) |
| Current assets | $bn | [42.8](/filings/0001140859-24-000177.md) | [44.9](/filings/0001140859-24-000019.md) | [44.2](/filings/0001140859-24-000072.md) | [47.3](/filings/0001140859-24-000119.md) | [47.7](/filings/0001140859-25-000131.md) | [50.0](/filings/0001140859-25-000034.md) | [46.5](/filings/0001140859-25-000083.md) | [48.8](/filings/0001140859-25-000122.md) | [52.2](/filings/0001140859-26-000034.md) | [54.2](/filings/0001140859-26-000006.md) | [53.1](/filings/0001140859-26-000020.md) | [55.3](/filings/0001140859-26-000034.md) |
| Total assets | $bn | [62.6](/filings/0001140859-24-000177.md) | [64.7](/filings/0001140859-24-000019.md) | [63.9](/filings/0001140859-24-000072.md) | [66.8](/filings/0001140859-24-000119.md) | [67.1](/filings/0001140859-25-000131.md) | [69.1](/filings/0001140859-25-000034.md) | [71.2](/filings/0001140859-25-000083.md) | [74.0](/filings/0001140859-25-000122.md) | [76.6](/filings/0001140859-26-000034.md) | [78.4](/filings/0001140859-26-000006.md) | [81.7](/filings/0001140859-26-000020.md) | [83.8](/filings/0001140859-26-000034.md) |
| Current liabilities | $bn | [48.8](/filings/0001140859-24-000177.md) | [50.8](/filings/0001140859-24-000019.md) | [49.8](/filings/0001140859-24-000072.md) | [53.0](/filings/0001140859-24-000119.md) | [54.3](/filings/0001140859-25-000131.md) | [54.5](/filings/0001140859-25-000034.md) | [53.3](/filings/0001140859-25-000083.md) | [54.0](/filings/0001140859-25-000122.md) | [57.8](/filings/0001140859-26-000034.md) | [59.1](/filings/0001140859-26-000006.md) | [56.1](/filings/0001140859-26-000020.md) | [59.2](/filings/0001140859-26-000034.md) |
| Long-term debt | $bn | [4.1](/filings/0001140859-24-000177.md) | [4.2](/filings/0001140859-24-000019.md) | [4.2](/filings/0001140859-24-000072.md) | [4.2](/filings/0001140859-24-000119.md) | [3.8](/filings/0001140859-25-000131.md) | [5.9](/filings/0001140859-25-000034.md) | [7.1](/filings/0001140859-25-000083.md) | [8.0](/filings/0001140859-25-000122.md) | [7.5](/filings/0001140859-26-000034.md) | [7.6](/filings/0001140859-26-000006.md) | [12.2](/filings/0001140859-26-000020.md) | [11.4](/filings/0001140859-26-000034.md) |
| Current portion of debt | $bn | [0.6](/filings/0001140859-24-000177.md) | [0.6](/filings/0001140859-24-000019.md) | [1.1](/filings/0001140859-24-000072.md) | [0.6](/filings/0001140859-24-000119.md) | [0.6](/filings/0001140859-25-000131.md) | [2.2](/filings/0001140859-25-000034.md) | [0.8](/filings/0001140859-25-000083.md) | [0.2](/filings/0001140859-25-000122.md) | [0.1](/filings/0001140859-26-000034.md) | [0.3](/filings/0001140859-26-000006.md) | [0.2](/filings/0001140859-26-000020.md) | [0.3](/filings/0001140859-26-000034.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [0.5](/filings/0001140859-24-000177.md) | [0.9](/filings/0001140859-24-000019.md) | [1.1](/filings/0001140859-24-000072.md) | [0.9](/filings/0001140859-24-000119.md) | [0.6](/filings/0001140859-25-000131.md) | [0.2](/filings/0001140859-25-000034.md) | [1.0](/filings/0001140859-25-000083.md) | [2.0](/filings/0001140859-25-000122.md) | [1.5](/filings/0001140859-26-000034.md) | [1.9](/filings/0001140859-26-000006.md) | [3.4](/filings/0001140859-26-000020.md) | [3.1](/filings/0001140859-26-000034.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,827 d](/filings/0001140859-25-000131.md) | [885](/filings/0001140859-25-000034.md) | [(878) d](/filings/0001140859-25-000083.md) | [2,478 d](/filings/0001140859-25-000122.md) | [1,000 d](/filings/0001140859-25-000131.md) | [(2,719)](/filings/0001140859-26-000006.md) | [3,351 d](/filings/0001140859-26-000020.md) | [109 d](/filings/0001140859-26-000034.md) | [3,133 d](/filings/0001140859-25-000131.md) | [(2,305)](/filings/0001140859-26-000006.md) | [1,339 d](/filings/0001140859-26-000020.md) | [2,654 d](/filings/0001140859-26-000034.md) |
| Capital expenditure | $m | [175 d](/filings/0001140859-25-000131.md) | [74.2](/filings/0001140859-25-000034.md) | [113 d](/filings/0001140859-25-000083.md) | [118 d](/filings/0001140859-25-000122.md) | [182 d](/filings/0001140859-25-000131.md) | [106](/filings/0001140859-26-000006.md) | [129 d](/filings/0001140859-26-000020.md) | [183 d](/filings/0001140859-26-000034.md) | [250 d](/filings/0001140859-25-000131.md) | [119](/filings/0001140859-26-000006.md) | [166 d](/filings/0001140859-26-000020.md) | [226 d](/filings/0001140859-26-000034.md) |
| Dividends paid | $m | [98.3 d](/filings/0001140859-25-000131.md) | [106](/filings/0001140859-25-000034.md) | [107 d](/filings/0001140859-25-000083.md) | [103 d](/filings/0001140859-25-000122.md) | [101 d](/filings/0001140859-25-000131.md) | [111](/filings/0001140859-26-000006.md) | [111 d](/filings/0001140859-26-000020.md) | [107 d](/filings/0001140859-26-000034.md) | [108 d](/filings/0001140859-25-000131.md) | [127](/filings/0001140859-26-000006.md) | [117 d](/filings/0001140859-26-000020.md) | [117 d](/filings/0001140859-26-000034.md) |
| Share repurchases | $m | [274 d](/filings/0001140859-25-000131.md) | [386](/filings/0001140859-24-000019.md) | [50.8 d](/filings/0001140859-24-000072.md) | [550 d](/filings/0001140859-24-000119.md) | [505 d](/filings/0001140859-25-000131.md) | [385](/filings/0001140859-25-000034.md) | [50.0 d](/filings/0001140859-25-000083.md) | [0.0 d](/filings/0001140859-25-000122.md) | [0.1 d](/filings/0001140859-25-000131.md) | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [206](/filings/0001140859-24-000019.md) | [204](/filings/0001140859-24-000072.md) | [204](/filings/0001140859-24-000119.md) | [202](/filings/0001140859-25-000034.md) | [201](/filings/0001140859-25-000083.md) | [200](/filings/0001140859-25-000122.md) | [195](/filings/0001140859-26-000006.md) | [195](/filings/0001140859-26-000020.md) | [195](/filings/0001140859-26-000034.md) | [195](/filings/0001140859-26-000006.md) | [195](/filings/0001140859-26-000020.md) | [194](/filings/0001140859-26-000034.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 190,827,165 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001140859-26-000034.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.